제품 > 항체 > Biosimilar Antibody

Human EGFR Monoclonal Antibody (YR0011)

Datasheet

ABclonal: - Human EGFR Monoclonal Antibody (YR0011)

Direct ELISA binding curve demonstrating the recognition of Human Anti-Human EGFR (Research Grade Cetuximab Biosimilar) Monoclonal Antibody to EGFR. The target protein was coated onto the microplate well surface, followed by binding of the antibody. A donkey anti-human IgG HRP conjugate was used for detection.

ABclonal: - Human EGFR Monoclonal Antibody (YR0011)

Human EGFR SPR assay. Determined through SPR assay, the Human Anti-Human EGFR (Research Grade Cetuximab Biosimilar) Monoclonal Antibody is capable of binding to Human EGFR with an affinity constant of 0.2295 nM.

ABclonal:Flow CytoMetry - Human EGFR Monoclonal Antibody (YR0011)

Detection of EGFR in A431 cell line by Flow Cytometry. A431 cell line was stained with Human Anti-Human EGFR( Cetuximab Biosimilar) Monoclonal Antibody followed by APC conjugated Anti-Human IgG Secondary Antibody, or unstained cells (open yellow histogram).

Basic Information

CloneCetuximab Biosimilar
Molecular Weight150 kDa
Endotoxin<1EU/mg (<0.001EU/μg)Determined by LAL gel clotting assay
Sterility0.2 μm filtration
Aggregation<5% Determined by SECP
Purity>95% Determined by SEC-HPLC
ProductionPurified from cell culture supernatant in an animal-free facility
PurificationProtein A or G purification
Storage2 - 8°C for up to 4 weeks and -80°C for long term storage (Avoid repeated freezing and thawing)
Cetuximab, a chimeric (mouse/human) anti-EGFR monoclonal antibody, is an EGFR inhibitor used for the treatment of metastatic colorectal cancer and head and neck cancer. Cetuximab binds to EGFR and turns off the uncontrolled growth in cancers with EGFR mutations.Cetuximab can be used for treatment of KRAS wild type colon cancer but has little or no effect in colorectal tumors harboring a KRAS mutation. Before treatment using Erbitux, it is better to do a diagnosis using the real time PCR companion diagnostic test for KRAS, the therascreen KRAS test.
IsotypeHuman IgG1 kappa
ImmunogenHuman EGFR
RecommendedIsotype Control(s)In Vivo Grade Recombinant Human IgG1 Kappa Isotype Control Antibody
Recommended Dilution Buffer1×PBS pH 7.0
ABclonal: - Human EGFR Monoclonal Antibody (YR0011)}

- Human EGFR Monoclonal Antibody (YR0011)

Direct ELISA binding curve demonstrating the recognition of Human Anti-Human EGFR (Research Grade Cetuximab Biosimilar) Monoclonal Antibody to EGFR. The target protein was coated onto the microplate well surface, followed by binding of the antibody. A donkey anti-human IgG HRP conjugate was used for detection.
ABclonal: - Human EGFR Monoclonal Antibody (YR0011)}

- Human EGFR Monoclonal Antibody (YR0011)

Human EGFR SPR assay. Determined through SPR assay, the Human Anti-Human EGFR (Research Grade Cetuximab Biosimilar) Monoclonal Antibody is capable of binding to Human EGFR with an affinity constant of 0.2295 nM.
ABclonal:Flow CytoMetry - Human EGFR Monoclonal Antibody (YR0011)}

Flow CytoMetry - Human EGFR Monoclonal Antibody (YR0011)

Detection of EGFR in A431 cell line by Flow Cytometry. A431 cell line was stained with Human Anti-Human EGFR( Cetuximab Biosimilar) Monoclonal Antibody followed by APC conjugated Anti-Human IgG Secondary Antibody, or unstained cells (open yellow histogram).

* For research use only. Not for therapeutic or diagnostic purposes.

항체 (42)

재조합 단백질 (8)

제품 (3)

ELISA 키트 (1)